Skip to Content

Join the 'Herpes Simplex, Mucocutaneous / Immunocompetent Host' group to help and get support from people like you.

Herpes Simplex, Mucocutaneous / Immunocompetent Host News

Genital Herpes Vaccine Shows Promise in Animal Trials

Posted 20 Jan 2017 by Drugs.com

THURSDAY, Jan. 19, 2017 – A new vaccine for genital herpes could be nearing human clinical trials, researchers say. The vaccine has proven effective in animals against herpes simplex virus 2, the sexually transmitted virus that causes genital herpes, according to a new report. The new "trivalent" vaccine targets three different parts of the virus, shutting down its ability to enter cells and to ...

Pubic Grooming Tied to Higher STD Rates

Posted 6 Dec 2016 by Drugs.com

MONDAY, Dec. 5, 2016 – Brazilian bikini waxing and similar forms of personal grooming may be all the rage, but they come with a heightened risk of acquiring a sexually transmitted disease, new research suggests. The study found that frequent groomers of pubic hair are three to four times more likely to contract a sexually transmitted infection, such as herpes, human papillomavirus (HPV) or ...

Injections Might Help Prevent Genital Herpes Transmission for Months: Study

Posted 3 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 2, 2016 – Three injections of a therapeutic vaccine may control genital herpes as effectively as daily pills for at least a year, a new study suggests. Researchers tested the experimental vaccine in 310 people with herpes from 17 centers around the United States. The three shots, administered three weeks apart, appeared to reduce patients' genital lesions and the process of ...

Task Force: Routine Genital Herpes Screening Not Recommended

Posted 2 Aug 2016 by Drugs.com

TUESDAY, Aug. 2, 2016 – A U.S. federal task force is prepared to recommend that teens, adults and pregnant women not be routinely tested for genital herpes if they don't have signs of infection. About one in every six Americans between the ages of 14 and 49 has genital herpes, according to the U.S. Centers for Disease Control and Prevention. The disease, which is transmitted through vaginal, ...

Experimental Genital Herpes Drug Shows Promise

Posted 20 Jun 2016 by Drugs.com

MONDAY, June 20, 2016 – An experimental immune-boosting treatment for genital herpes shows promise, researchers report. The drug, called GEN-003, may reduce both virus activity and the number of days with recurrent herpes in patients. The treatment is given in a series of three injections and appears to last for up to one year, the investigators said. The researchers tested the vaccine on 310 ...

Ask a Question

Further Information

Related Condition Support Groups

Herpes Simplex

Related Drug Support Groups

Valtrex, acyclovir, valacyclovir, Famvir, famciclovir